aplaviroc inn codenamed entry inhibitor belongs class developed treatment hiv developed glaxosmithkline october studies aplaviroc discontinued due liver toxicity authors claimed evidence poor efficacy may contributed termination drugs ascent study one discontinued trials showed aplaviroc undereffective many patients even high antiinfective drug article stub help wikipedia expanding httpsenwikipediaorgwikiaplaviroc